Lecture Series Logo: NHLBI 70 Years of Discovery

Unraveling the Mysteries of Cardiovascular Disease: Lessons from NHLBI’s Framingham Heart Study

Natcher Auditorium A & Auditorium B


Please join us for our first lecture, "Unraveling the Mysteries of Cardiovascular Disease: Lessons from NHLBI’s Framingham Heart Study" with Dr. Daniel Levy of NHLBI and Boston University School of Medicine.

This year, 2018, marks the 70th Anniversary of the establishment of the National Heart, Lung, and Blood Institute. 

NHLBI began as the National Heart Institute on June 16, 1948, when President Harry S. Truman signed the National Heart Act. The Framingham Heart Study began the same year. In 1969, the Institute expanded its mission (and name) to cover research on lung diseases, and in 1976, the Institute grew further to include blood disorders.

To commemorate the Institute's 70th anniversary and showcase important investments in scientific research, NHLBI will feature lectures throughout the year from prominent thought leaders representing areas of high scientific priority in heart, lung, blood, and sleep disorders.

The talks will be available to the public in-person and online via videocast.


Please watch the videocast of the lecture:

NIH Record

NHLBI Marks Year 70 of Iconic Framingham Heart Study



12:00 pm
Unraveling the Mysteries of Cardiovascular Disease
Lessons from NHLBI's Framingham Heart Study

Select Speakers

The Framingham Heart Study was among the first long-term observational studies to investigate the causes and outcomes of chronic, non-infectious disease. Initiated in 1948, it has followed more than 14,000 participants from three generations living in Framingham, Massachusetts. In his presentation titled Unraveling the Mysteries of Cardiovascular Disease: Lessons from the NHLBI’s Framingham Heart Study, Dr. Levy will take us back to the early 20th century, when heart disease emerged as the leading cause of death in the U.S., which it remains to this day. He will describe how the study identified major risk factors for heart disease – including high blood pressure, high cholesterol, smoking, physical inactivity, and overweight – and how this knowledge has led to successful interventions for heart disease and stroke. He also will highlight how the study has continued to evolve and focus on new research areas, staying at the cutting edge of science and medicine for 70 years.
Headshot of Dr. Daniel Levy
National Heart, Lung, and Blood Institute
Daniel Levy, M.D., is Chief of the Population Sciences Branch of the National Heart, Lung, and Blood Institute, Professor of Medicine at Boston University School of Medicine, and Director of the NHLBI’s Framingham Heart Study.
Daniel Levy, M.D.